Join Growin Stock Community!
Back to CMG.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

operating-expenses-chart

CMG Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25, CMG reported SG&A Expenses of USD 160M, while R&D Expenses remained at USD 0. This latest data point continues the trend of zero R&D spending and highlights a moderate level of SG&A outlay for the quarter. From Q1'23 to Q4'25, SG&A Expenses for CMG have shown moderate fluctuations, peaking at USD 205M in Q1'24 and reaching a low of USD 127M in Q3'24. The absence of R&D Expenses throughout the entire period indicates a consistent allocation strategy, with operating expenses primarily driven by SG&A. Overall, the trend reflects stable but variable SG&A spending, with no investment in R&D over the observed quarters.